| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/19/2008 | EP1306431B1 Tumor antigen |
| 03/19/2008 | EP1012240B1 Cancer immunotherapy with semi-allogeneic cells |
| 03/19/2008 | EP1009831B1 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses |
| 03/19/2008 | EP0971735B1 Methods and compositions for treating inflammatory bowel disease |
| 03/19/2008 | CN101146909A Antigen binding molecules directed to MCSP and having increased Fc receptor binding affinity and effector function |
| 03/19/2008 | CN101146827A HIV TAT-CD4 hybried molecules and methods of use thereof |
| 03/19/2008 | CN101146825A A molecule and chimeric molecules thereof |
| 03/19/2008 | CN101146554A Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 03/19/2008 | CN101146553A Anti-CTLA4 antibody and indolinone combination therapy for treatment of cancer |
| 03/19/2008 | CN101146552A Therapy of prostate cancer with CTLA4 antibodies and hormonal therapy |
| 03/19/2008 | CN101146551A Adjuvant composition comprising aluminium phosphate and 3D-MPL |
| 03/19/2008 | CN101146550A Methods to elicit, enhance and sustain immune responses against MHC class I-restricted epitopes, for prophylactic or therapeutic purposes |
| 03/19/2008 | CN101146548A Methods for treating lymphomas using a combination of a chemotherapeutic agent and IL-2 and optionally an anti-CD20 antibody |
| 03/19/2008 | CN101146547A Use of myostatin (GDF-8) antagonists for improving wound healing and preventif fibrotic disease |
| 03/19/2008 | CN101146546A Muscle regeneration |
| 03/19/2008 | CN101146518A Chemically defined stabiliser composition |
| 03/19/2008 | CN101144079A Preparation method for expression infectious bursa of Fabricius virus VP3 gene coding protein immortalized cell |
| 03/19/2008 | CN101144062A Lactobacillus casei strain and application for products thereof in bird immunity |
| 03/19/2008 | CN101143221A Central airway administration for systemic delivery of therapeutics |
| 03/19/2008 | CN101143216A Escherichia coli TolC antibody targeting effect improving drug-resistant bacteria sensitivity to antibiotic technology |
| 03/19/2008 | CN100375786C Recombinant MVA capable of expressing structural HCV antigens |
| 03/18/2008 | US7345151 Antagonists specific for denatured collagen and methods of using same |
| 03/18/2008 | US7345046 Using quinazoline type compound ; antiproliferative agents |
| 03/18/2008 | US7345045 Pyrido-pyrimidine compounds as medicaments |
| 03/18/2008 | US7344879 Peptide for use in the treatment of cell proliferation disorders |
| 03/18/2008 | US7344873 Using vector transformation to generate heat resistant viral particles |
| 03/18/2008 | US7344872 involves engineering a recombinant shuttle vector comprising a nucleic acid cassette encoding prokaryotic green fluorescent protein (GFP) operably linked to regulatory sequences which permit its expression in a host cell |
| 03/18/2008 | US7344842 Prion test |
| 03/18/2008 | US7344829 Methods for detecting the efficacy of anticancer treatments |
| 03/18/2008 | US7344724 proteins and genes codes, used for medical diagnosis, screening biological targets and as vaccines against gramnegative bacterial infections |
| 03/18/2008 | US7344722 Cold-adapted influenza virus |
| 03/18/2008 | US7344721 Polypeptide for the treatment of cancer and a method for preparation thereof |
| 03/18/2008 | US7344720 Vaccine composition |
| 03/18/2008 | US7344719 Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof |
| 03/18/2008 | US7344718 Yersinia species compositions |
| 03/18/2008 | US7344717 Use of erythropoietin in the treatment of rheumatoid arthritis |
| 03/18/2008 | US7344716 Transdiscal administration of specific inhibitors of pro-inflammatory cytokines |
| 03/18/2008 | US7344715 Method for treating multiple myeloma |
| 03/18/2008 | US7344714 Generation preferential antibody; construct peptide library, immunize cells, isolating and purify antisera from cells |
| 03/18/2008 | US7344713 Decreased fat absorption with an anti-lipase antibody |
| 03/18/2008 | US7344703 Mycobacterial sulfation pathway proteins and methods of use thereof |
| 03/18/2008 | CA2424977C Process for purifying antibody |
| 03/18/2008 | CA2329128C Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 03/18/2008 | CA2258878C Liposomal influenza vaccine composition and method |
| 03/18/2008 | CA2185043C Monoclonal antibodies recognizing tie-receptor and their use |
| 03/18/2008 | CA2167980C Cgrp antagonist used in a cosmetic composition; pharmaceutical or dermatologic composition produced |
| 03/18/2008 | CA2166102C Redirection of cellular immunity by receptor chimeras |
| 03/18/2008 | CA2089735C Ryegrass pollen allergen |
| 03/18/2008 | CA2015060C Novel antibody delivery system for biological response modifiers |
| 03/14/2008 | CA2568354A1 Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof |
| 03/13/2008 | WO2008031092A2 Immunostimulatory composition comprising lipoprotein in microalgae extract |
| 03/13/2008 | WO2008031056A2 Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 03/13/2008 | WO2008030931A2 Methods of treating tendonitis in a subject by using an anti-cytokine agent |
| 03/13/2008 | WO2008030638A2 Use of dmso and botulinum toxin therapy for urinary incontinence and related disorders |
| 03/13/2008 | WO2008030625A2 Antibodies against human melanoma-associated chondroitin sulphate proteoglycan (mcsp) |
| 03/13/2008 | WO2008030611A2 Antibodies to bone morphogenic proteins and receptors therefor and methods for their use |
| 03/13/2008 | WO2008030560A2 Hsv-1 and hsv-2 vaccines and methods of use thereof |
| 03/13/2008 | WO2008030538A2 Cancer stem cell-targeted cancer therapy |
| 03/13/2008 | WO2008030505A2 Methods and compositions for the treatment of antibody mediated neuropathies |
| 03/13/2008 | WO2008030260A2 Treatment of variola viral infections using a tissue factor inhibitor |
| 03/13/2008 | WO2008030251A1 Deglycosylated anti-amyloid beta antibodies |
| 03/13/2008 | WO2008030220A2 Chikungunya virus infectious clones and uses thereof |
| 03/13/2008 | WO2008030141A1 Use of nifuroxazide in the form of a component of a combined drug therapy for treating diseases associated with helicobacter pylori and a curing method for eradicating a causative agent |
| 03/13/2008 | WO2008029908A1 Stable lyophilized pharmaceutical preparation comprising antibody |
| 03/13/2008 | WO2008028963A2 Calreticulin for its use as a medication for the treatment of cancer in a mammal |
| 03/13/2008 | WO2008028957A2 Vaccine |
| 03/13/2008 | WO2008028956A1 Vaccine |
| 03/13/2008 | WO2008028929A1 Method for determining the quantity and quality of hybridomas as well as the use of hybridomas of suitable quality |
| 03/13/2008 | WO2008028686A2 Use of human cells of myeloid leukaemia origin for expression of antibodies |
| 03/13/2008 | WO2008028667A2 Use of glycolipids as adjuvants |
| 03/13/2008 | WO2008028535A1 Split-core-particles for the presentation of foreign molecules, especially for vaccine applications, and method for their production |
| 03/13/2008 | WO2008028501A1 Methods for blocking the interaction between nkp80 and its ligand aicl |
| 03/13/2008 | WO2008013797A3 Compositions and methods for macular degeneration |
| 03/13/2008 | WO2008010986A3 Methods of modulating angiogenesis |
| 03/13/2008 | WO2008006554A8 Glyco-engineered antibodies |
| 03/13/2008 | WO2008005315A9 Automatic injection device |
| 03/13/2008 | WO2007143442A3 A novel virulence determinant within the e2 structural glycoprotein of classical swine fever virus |
| 03/13/2008 | WO2007143090A3 Hepatocyte growth factor (hgf) binding proteins |
| 03/13/2008 | WO2007130697A3 Anti-ephb4 antibodies and methods using same |
| 03/13/2008 | WO2007125371A3 Process for making oligopeptides |
| 03/13/2008 | WO2007123400A9 Vaccine against nicotine addiction |
| 03/13/2008 | WO2007116360A3 Antibodies that bind human protein tyrosine phosphatase beta (hptpbeta) and uses thereof |
| 03/13/2008 | WO2007111714A3 Il-21 antagonists |
| 03/13/2008 | WO2007109376A3 Anti-tumor cell antigen antibody therapeutics |
| 03/13/2008 | WO2007103225A3 Engineered listeria and methods of use thereof |
| 03/13/2008 | WO2007084708A3 Tat-028 and methods of assessing and treating cancer |
| 03/13/2008 | WO2001028491A3 Method and composition for the treatment of dermatologic diseases |
| 03/13/2008 | US20080064857 Immunoglobulin for use in diagnosis, prevention and treatment of metabolic disorders of pancreas |
| 03/13/2008 | US20080064190 Manufacturing method of semiconductor device and semiconductor manufacturing device |
| 03/13/2008 | US20080064104 Antagonists and agonists of ldcam and methods of use |
| 03/13/2008 | US20080064096 Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
| 03/13/2008 | US20080063717 Anti-NCR antibody or immunoreactive fragments and an interleukin, cytokine; administered together or separately; tablet, powder, pastes, patches, granules, microgranules, nanoparticules, colloid solution, aqueous solution, injectable solutions, sprays, or liposomes; subcutaneous injection |
| 03/13/2008 | US20080063696 Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant |
| 03/13/2008 | US20080063667 ProDer P 1 Expressed in a Prokaryotic Cell |
| 03/13/2008 | US20080063666 New lactic bacteria useful as probiotics |
| 03/13/2008 | US20080063665 vaccine contains two or more serotypes of meningococcus; membrane proteins, conjugated capsular saccharide; immunization against disease |
| 03/13/2008 | US20080063664 making a vaccine by constructing a plasmid comprising a nucleotide sequence encoding proteins of the virus, transfecting cells and gene expression viral proteins; detecting and prevent an infection of SARS-CoV by administering the vaccine; severe acute respiratory syndrome coronavirus |
| 03/13/2008 | US20080063663 immunizing a cat with vaccine against a hemorrhagic feline calicivirus (hFCV); veterinary medicine |
| 03/13/2008 | US20080063662 Vaccine |
| 03/13/2008 | US20080063661 treating a wart with a fusion protein comprising (1) a heat shock protein and (2) a human papilloma virus (HPV) protein; Mycobacterium bovis heat shock protein; HPV is an E7 protein; cervical dysplasia, anal cancer, anal dysplasia |